Emergent BioSolutions has entered a strategic financial investment agreement with Swiss Rockets to support infrastructure ...

Emergent BioSolutions is investing in Swiss biotech Rocketvax, inking a deal designed to fuel the preclinical company’s R&D.

Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, and Rocketvax Ltd, one of Switzerland’s next ...

Emergent BioSolutions (EBS) and Rocketvax announced entry into an agreement for Emergent’s strategic financial investment into Swiss Rockets, ...

USA-based Emergent BioSolutions (NYSE: EBS) and Swiss vaccines firm Rocketvax have announced an agreement. One part of the ...

As part of the investment, Emergent would lead U.S. manufacturing and commercialization efforts for four of Rocketvax’s ...